Literature DB >> 14662844

Differential effects of IL-1 alpha and IL-1 beta on tumorigenicity patterns and invasiveness.

Xiaoping Song1, Elena Voronov, Tatyana Dvorkin, Eyal Fima, Emanuela Cagnano, Daniel Benharroch, Yaakov Shendler, Olle Bjorkdahl, Shraga Segal, Charles A Dinarello, Ron N Apte.   

Abstract

In this study, we show that distinct compartmentalization patterns of the IL-1 molecules (IL-1alpha and IL-1beta), in the milieu of tumor cells that produce them, differentially affect the malignant process. Active forms of IL-1, namely precursor IL-1alpha (pIL-1alpha), mature IL-1beta (mIL-1beta), and mIL-1beta fused to a signal sequence (ssIL-1beta), were transfected into an established fibrosarcoma cell line, and tumorigenicity and antitumor immunity were assessed. Cell lines transfected with pIL-1alpha, which expresses IL-1alpha on the membrane, fail to develop local tumors and activate antitumor effector mechanisms, such as CTLs, NK cells, and high levels of IFN-gamma production. Cells transfected with secretable IL-1beta (mIL-1beta and ssIL-1beta) were more aggressive than wild-type and mock-transfected tumor cells; ssIL-1beta transfectants even exhibited metastatic tumors in the lungs of mice after i.v. inoculation (experimental metastasis). In IL-1beta tumors, increased vascularity patterns were observed. No detectable antitumor effector mechanisms were observed in spleens of mice injected with IL-1beta transfectants, mock-transfected or wild-type fibrosarcoma cells. Moreover, in spleens of mice injected with IL-1beta transfectants, suppression of polyclonal mitogenic responses (proliferation, IFN-gamma and IL-2 production) to Con A was observed, suggesting the development of general anergy. Histologically, infiltrating mononuclear cells penetrating the tumor were seen at pIL-1alpha tumor sites, whereas in mIL-1beta and ssIL-1beta tumor sites such infiltrating cells do not penetrate inside the tumor. This is, to our knowledge, the first report on differential, nonredundant, in vivo effects of IL-1alpha and IL-1beta in malignant processes; IL-1alpha reduces tumorigenicity by inducing antitumor immunity, whereas IL-1beta promotes invasiveness, including tumor angiogenesis, and also induces immune suppression in the host.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14662844     DOI: 10.4049/jimmunol.171.12.6448

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  46 in total

Review 1.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

2.  The Interleukin (IL)-1R1 pathway is a critical negative regulator of PyMT-mediated mammary tumorigenesis and pulmonary metastasis.

Authors:  Maryse Dagenais; Jeremy Dupaul-Chicoine; Todd Douglas; Claudia Champagne; Alexandre Morizot; Maya Saleh
Journal:  Oncoimmunology       Date:  2017-02-06       Impact factor: 8.110

3.  Topographical changes in extracellular matrix: Activation of TLR4 signaling and solid tumor progression.

Authors:  Rhiannon M Kelsh; Paula J McKeown-Longo
Journal:  Trends Cancer Res       Date:  2013-01-01

4.  Concentration of cytokines in age-related macular degeneration after consecutive intravitreal bevacizumab injection.

Authors:  Mi In Roh; Su Jin Lim; Ji Min Ahn; Jong Baek Lim; Oh Woong Kwon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-09       Impact factor: 3.117

5.  IL-1 in Colon Inflammation, Colon Carcinogenesis and Invasiveness of Colon Cancer.

Authors:  Elena Voronov; Ron N Apte
Journal:  Cancer Microenviron       Date:  2015-12-19

Review 6.  Inflammasome activation of IL-1 family mediators in response to cutaneous photodamage.

Authors:  Tahseen H Nasti; Laura Timares
Journal:  Photochem Photobiol       Date:  2012-07-09       Impact factor: 3.421

7.  Individual differences in pre-carcinogen cytokine and corticosterone concentrations and depressive-like behavior predict tumor onset in rats exposed to a carcinogen.

Authors:  Leah M Pyter; Brian J Prendergast
Journal:  Psychoneuroendocrinology       Date:  2012-10-06       Impact factor: 4.905

8.  IL-1B -31T>C promoter polymorphism is associated with gastric stump cancer but not with early onset or conventional gastric cancers.

Authors:  R Sitarz; W W J de Leng; M Polak; F H M Morsink; O Bakker; W P Polkowski; R Maciejewski; G J A Offerhaus; A N Milne
Journal:  Virchows Arch       Date:  2008-08-08       Impact factor: 4.064

9.  Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells.

Authors:  Irina Nazarenko; Rachid Marhaba; Eli Reich; Elena Voronov; Mario Vitacolonna; Dagmar Hildebrand; Elena Elter; Mohini Rajasagi; Ron N Apte; Margot Zöller
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

Review 10.  Function and regulation of IL-1α in inflammatory diseases and cancer.

Authors:  Ankit Malik; Thirumala-Devi Kanneganti
Journal:  Immunol Rev       Date:  2018-01       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.